Vannair contains two medicines in one puffer – one to help prevent your asthma occurring, and one to control your asthma symptoms for at least 12 hours – and it opens your airways in just 1-3 minutes 1, so you can feel it working right away. 2
Prescription Medicine. Use strictly as directed. Do not exceed maximum dose. If symptoms continue or you experience side effects, see your healthcare professional. Vannair is indicated for the regular treatment of asthma.
Contains budesonide 100ug or 200ug per dose (preventer) and eformoterol 6ug (symptom controller). Tell your doctors if you have thyroid problems, heart problems, diabetes, problems with potassium levels, pregnancy, breast feeding.
Do not use if you are allergic to budesonide or eformoterol. Common side effects: mild irritation in the throat, coughing, hoarseness, thrush (fungal infection in mouth and throat), headache, trembling, fast or irregular heartbeat. Rarely, allergic reactions.
Not all patients are eligible for treatment with Vannair. Fully funded under certain criteria. Your doctor’s fee and a prescription fee will apply. For Consumer Medicine Information see www.medsafe.govt.nz. Vannair is a trademark of AstraZeneca Group. AstraZeneca Limited, 299 Private Bag 92175, Auckland 1142, Telephone (09) 306 5650 Facsimile (09) 306 5651.
TAPS NA 5190 essence AZ5450 10 August 2011
© AstraZeneca 2012
* Vannair [budesonide/eformoterol] demonstrated a more rapid onset of clinically significant bronchodilation and a greater percentage of patients who perceived their medication working right away versus budesonide or placebo.2
1. Vannair Datasheet, 13 March 2007
2. Kaiser H et al. Ann Allergy Asthma Immunol 2008;101:295-303.
